Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Clinical spectrum & pathogenesis of Clostridium difficile associated diseases.

Vaishnavi C.

Indian J Med Res. 2010 Apr;131:487-99. Review.

2.

Clostridium difficile infection: clinical spectrum and approach to management.

Vaishnavi C.

Indian J Gastroenterol. 2011 Dec;30(6):245-54. doi: 10.1007/s12664-011-0148-y. Epub 2011 Dec 20. Review.

PMID:
22183580
3.

Current and future treatment modalities for Clostridium difficile-associated disease.

Halsey J.

Am J Health Syst Pharm. 2008 Apr 15;65(8):705-15. doi: 10.2146/ajhp070077. Review. Erratum in: Am J Health Syst Pharm. 2008 Jun 1;65(11):998.

PMID:
18387898
4.

Clostridium difficile infection.

Gröschel DH.

Crit Rev Clin Lab Sci. 1996;33(3):203-45. Review.

PMID:
8828001
5.

Clinical impact of Clostridium difficile colonization.

Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC.

J Microbiol Immunol Infect. 2015 Jun;48(3):241-8. doi: 10.1016/j.jmii.2014.04.011. Epub 2014 Jun 2. Review.

6.

Emergence of Clostridium difficile-associated disease in North America and Europe.

Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control.

Clin Microbiol Infect. 2006 Oct;12 Suppl 6:2-18. Review.

7.

New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.

DuPont HL, Garey K, Caeiro JP, Jiang ZD.

Curr Opin Infect Dis. 2008 Oct;21(5):500-7. doi: 10.1097/QCO.0b013e32830f9397. Review.

PMID:
18725800
8.

Clostridium difficile.

Kyne L, Farrell RJ, Kelly CP.

Gastroenterol Clin North Am. 2001 Sep;30(3):753-77, ix-x. Review.

PMID:
11586556
9.

Clostridium difficile infection in horses: a review.

Diab SS, Songer G, Uzal FA.

Vet Microbiol. 2013 Nov 29;167(1-2):42-9. doi: 10.1016/j.vetmic.2013.03.032. Epub 2013 Apr 10. Review.

10.

Clostridium difficile: recent epidemiologic findings and advances in therapy.

McMaster-Baxter NL, Musher DM.

Pharmacotherapy. 2007 Jul;27(7):1029-39. Review.

PMID:
17594209
11.

New trends in Clostridium difficile virulence and pathogenesis.

Denève C, Janoir C, Poilane I, Fantinato C, Collignon A.

Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S24-8. doi: 10.1016/S0924-8579(09)70012-3. Review.

PMID:
19303565
12.

Clostridium difficile infection: a comprehensive review.

Kachrimanidou M, Malisiovas N.

Crit Rev Microbiol. 2011 Aug;37(3):178-87. doi: 10.3109/1040841X.2011.556598. Epub 2011 May 24. Review.

PMID:
21609252
13.

Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence.

Deshpande A, Pant C, Jain A, Fraser TG, Rolston DD.

Curr Med Res Opin. 2008 Feb;24(2):329-33. Review.

PMID:
18067688
14.

The role of toxin A and toxin B in the virulence of Clostridium difficile.

Carter GP, Rood JI, Lyras D.

Trends Microbiol. 2012 Jan;20(1):21-9. doi: 10.1016/j.tim.2011.11.003. Epub 2011 Dec 7. Review.

PMID:
22154163
15.

Clostridium difficile-associated diarrhoea.

Elliott B, Chang BJ, Golledge CL, Riley TV.

Intern Med J. 2007 Aug;37(8):561-8. Review.

PMID:
17640189
16.

Clostridium difficile associated infection, diarrhea and colitis.

Hookman P, Barkin JS.

World J Gastroenterol. 2009 Apr 7;15(13):1554-80. Review.

17.

The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options.

Postma N, Kiers D, Pickkers P.

Int J Antimicrob Agents. 2015 Dec;46 Suppl 1:S47-50. doi: 10.1016/j.ijantimicag.2015.11.001. Epub 2015 Nov 3. Review.

PMID:
26612229
18.
19.

Clostridium difficile in food--innocent bystander or serious threat?

Weese JS.

Clin Microbiol Infect. 2010 Jan;16(1):3-10. doi: 10.1111/j.1469-0691.2009.03108.x. Review.

20.

Best strategies in recurrent or persistent Clostridium difficile infection.

Cocanour CS.

Surg Infect (Larchmt). 2011 Jun;12(3):235-9. doi: 10.1089/sur.2010.080. Epub 2011 Jul 18. Review.

PMID:
21767157

Supplemental Content

Support Center